This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: ARNA, F, BRCM, QCOM


Actuant (ATU) downgraded at Citigroup to Neutral from Buy, Citigroup said. $29 price target. More balanced risk/reward outlook.

Broadcom (BRCM) rated new Buy at Cantor. $40 price target. Infrastructure business trends remain strong and the NetLogic purchase should boost growth.

Dolby (DLB) rated new Sell at Goldman. $39 price target. Company faces multiple growth headwinds.

Ford Motor (F - Get Report) rated new Hold at Stifel. Company had been losing market share but is now better positioned for the next major product cycle.

First Niagara (FNFG) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $9 price target. Stock appears oversold and sports a 4% dividend yield.

Gartner (IT) rated new Market Perform at Wells. IT was initiated with a Market Perform rating, Wells Fargo said. Company is leveraged to near-term IT spending concerns.

LKQ (LKQ) downgraded at Baird from Outperform to Neutral, Robert Baird said. Valuation call, based on a $37 price target.

McGraw-Hill (MHP) upgraded at Benchmark from Hold to Buy, Benchmark said. $53 price target. Company has strong growth prospects in finance and can unlock value by separating the education business.

Microsemi (MSCC) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call, following the recent pullback.

Qualcomm (QCOM - Get Report) rated new Buy at Cantor Fitzgerald. $66 price target. Long-term trends remain positive for wireless devices.

Riverbed (RVBD) rated new Strong Buy at Needham. $25 price target. Stock looks oversold at current levels.

Spectra Energy (SE) upgraded at UBS to Buy from Neutral, UBS said. $31 price target. Prices already reflect NGL weakness.

Veeco Instruments (VECO) rated new Equal-weight at Piper. Overall market outlook remains uncertain.

Western Gas Partners (WES) upgraded at UBS to Buy from Neutral, UBS said. $48 price target. Continue to expect strong distribution growth.

Xylem (XYL) downgraded at Goldman to Sell, Goldman Sachs said. $24 price target. Company is leveraged to softer European and municipal water markets.


Arena Pharmaceuticals (ARNA - Get Report) numbers increased at BMO. ARNA estimates were raised through 2013, BMO Capital said. Company received better labeling in its FDA approval. Market Perform rating and new $12 price target.

Arena Pharmaceuticals target raised at Jefferies. Shares of ARNA now seen reaching $20, Jefferies said. FDA approves Lorcaserin. Buy rating.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BRCM $0.00 0.00%
ARNA $1.71 -0.58%
F $13.62 0.44%
QCOM $51.11 1.17%
RVBD $20.99 -0.05%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs